Diabetes drug lowers risk of cardiovascular complications, kidney disease

The glucose-lowering drug liraglutide safely and effectively decreases the overall risk of heart attack, stroke, or cardiovascular death, kidney disease, and death from all causes for people with type 2 diabetes, according to data from the large, multinational LEADER clinical trial.